P
Purple Biotech Ltd
TASE:PPBT
Purple Biotech Ltd
TASE:PPBT
Price:
1
ILS
Market Closed
Market Cap:
₪17.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sihui Fuji Electronics Technology Co Ltd
SZSE:300852
|
CN |
Purple Biotech Ltd
EPS (Diluted)
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Purple Biotech Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Purple Biotech Ltd
TASE:PPBT
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
EPS (Diluted)
$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
EPS (Diluted)
-$2
|
CAGR 3-Years
30%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
67%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
EPS (Diluted)
-₪1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
No Stocks Found
Purple Biotech Ltd
Glance View
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
PPBT
Intrinsic Value
1.1
ILS
Undervaluation 9%
P
See Also
What is Purple Biotech Ltd's EPS (Diluted)?
EPS (Diluted)
0
USD
0
USD
Based on the financial report for Sep 30, 2025, Purple Biotech Ltd's EPS (Diluted) amounts to 0 USD.
